TWD 695.0
(-3.34%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 5.24 Billion TWD | 117.34% |
2022 | 1.94 Billion TWD | 80.84% |
2021 | 1.07 Billion TWD | 369.51% |
2020 | 229.51 Million TWD | -33.45% |
2019 | 344.84 Million TWD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | 855.3 Million TWD | -26.9% |
2024 Q1 | 1.01 Billion TWD | 41.34% |
2023 Q2 | 1.06 Billion TWD | -28.3% |
2023 Q4 | 718.71 Million TWD | -25.48% |
2023 FY | 4.23 Billion TWD | 117.34% |
2023 Q1 | 1.48 Billion TWD | 125.96% |
2023 Q3 | 964.41 Million TWD | -9.51% |
2022 Q3 | 643.33 Million TWD | 0.0% |
2022 FY | 1.94 Billion TWD | 80.84% |
2022 Q4 | 657.82 Million TWD | 2.25% |
2021 FY | 1.07 Billion TWD | 369.51% |
2020 FY | 229.51 Million TWD | -33.45% |
2019 FY | 344.84 Million TWD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Grape King Bio Ltd | 2.49 Billion TWD | -110.246% |
Standard Chem & Pharm CO., LTD. | 1.25 Billion TWD | -316.747% |
Maywufa Company Ltd. | 211.01 Million TWD | -2387.52% |
ScinoPharm Taiwan, Ltd. | 314.49 Million TWD | -1569.09% |
Lotus Pharmaceutical Co., Ltd. | 4.9 Billion TWD | -7.061% |
LIWANLI Innovation Co., Ltd. | - TWD | -Infinity% |
YungShin Global Holding Corporation | 929.61 Million TWD | -464.659% |
PhytoHealth Corporation | -121.67 Million TWD | 4413.994% |
SCI Pharmtech, Inc. | 160.3 Million TWD | -3174.572% |
Formosa Laboratories, Inc. | 674.97 Million TWD | -677.679% |
PharmaEssentia Corporation | - TWD | -Infinity% |